AU5292893A - 1-substituted oxindoles and azaoxindoles as novel cognition enhancers - Google Patents
1-substituted oxindoles and azaoxindoles as novel cognition enhancersInfo
- Publication number
- AU5292893A AU5292893A AU52928/93A AU5292893A AU5292893A AU 5292893 A AU5292893 A AU 5292893A AU 52928/93 A AU52928/93 A AU 52928/93A AU 5292893 A AU5292893 A AU 5292893A AU 5292893 A AU5292893 A AU 5292893A
- Authority
- AU
- Australia
- Prior art keywords
- azaoxindoles
- novel
- cognition enhancers
- substituted oxindoles
- oxindoles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000019771 cognition Effects 0.000 title 1
- 239000003623 enhancer Substances 0.000 title 1
- 150000005623 oxindoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US957152 | 1992-10-07 | ||
US07/957,152 US5296478A (en) | 1992-10-07 | 1992-10-07 | 1-substituted oxindoles as cognition enhancers |
PCT/US1993/009183 WO1994007891A1 (en) | 1992-10-07 | 1993-10-01 | 1-substituted oxindoles and azaoxindoles as novel cognition enhancers |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5292893A true AU5292893A (en) | 1994-04-26 |
Family
ID=25499153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52928/93A Abandoned AU5292893A (en) | 1992-10-07 | 1993-10-01 | 1-substituted oxindoles and azaoxindoles as novel cognition enhancers |
Country Status (7)
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744476A (en) * | 1994-06-27 | 1998-04-28 | Interneuron Pharmaceuticals, Inc. | Dopamine D1 agonists for the treatment of dementia |
DK0813411T3 (da) * | 1995-02-15 | 2002-05-13 | Takeda Chemical Industries Ltd | Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein |
HRP980429A2 (en) | 1997-08-14 | 1999-06-30 | Jianguo Yin | Crystalline 10,10-bis ((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone and an improved process for preparing the same |
US20050101929A1 (en) * | 2002-01-17 | 2005-05-12 | Andrew Waksmundzki | Absorbent core with three-dimensional sub-layer |
MY158766A (en) * | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
MY145694A (en) | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
AR053713A1 (es) * | 2005-04-20 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos heterociclicos y sus usos como agentes terapeuticos |
WO2008036282A1 (en) * | 2006-09-18 | 2008-03-27 | The Regents Of The University Of Californina | Upregulating activity or expression of bdnf to mitigate cognitive impairment in asymptomatic huntington's subjects |
RU2009117642A (ru) * | 2006-10-12 | 2010-11-20 | Ксенон Фармасьютикалз Инк. (Ca) | Применение спирооксиндоловых соединений в качестве терапевтических средств |
MX2009003874A (es) * | 2006-10-12 | 2009-04-22 | Xenon Pharmaceuticals Inc | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. |
US20110294842A9 (en) * | 2006-10-12 | 2011-12-01 | Xenon Pharmaceuticals Inc. | Spiro (furo [3, 2-c] pyridine-3-3' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
WO2010045197A1 (en) * | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
MX2011004055A (es) | 2008-10-17 | 2011-06-24 | Xenon Pharmaceuticals Inc | Compuestos de espiro-oxindol y su uso como agentes terapeuticos. |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
ES2467166T3 (es) * | 2009-10-14 | 2014-06-12 | Xenon Pharmaceuticals Inc. | Métodos de síntesis de compuestos de espiro-oxindol |
WO2011047173A2 (en) * | 2009-10-14 | 2011-04-21 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions for oral administration |
JP2013521232A (ja) | 2010-02-26 | 2013-06-10 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 局所投与のためのスピロオキシインドール化合物の医薬組成物および治療剤としてのその使用 |
US9682033B2 (en) | 2015-02-05 | 2017-06-20 | Teva Pharmaceuticals International Gmbh | Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound |
CN106565683B (zh) * | 2016-09-30 | 2019-03-12 | 江汉大学 | 一种合成3-羟基氧化吲哚衍生物的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3314954A (en) * | 1964-12-09 | 1967-04-18 | Parke Davis & Co | 1-(diloweralkylamino)-3-(aminoloweralkyl)-3-phenyloxindoles |
US3595866A (en) * | 1970-01-19 | 1971-07-27 | Parke Davis & Co | 1-amino-3-aminoalkyl-3-phenyloxindole-compounds |
US5173489A (en) * | 1986-04-10 | 1992-12-22 | The Dupont Merck Pharmaceutical Co. | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
AU3776589A (en) * | 1988-06-14 | 1990-01-12 | Schering Corporation | Heterobicyclic compounds having antiinflammatory activity |
EP0429685B1 (en) * | 1989-07-25 | 1997-10-29 | Taiho Pharmaceutical Company, Limited | Oxoindole derivative |
US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
US5278162A (en) * | 1992-09-18 | 1994-01-11 | The Du Pont Merck Pharmaceutical Company | 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man |
-
1992
- 1992-10-07 US US07/957,152 patent/US5296478A/en not_active Expired - Fee Related
-
1993
- 1993-10-01 WO PCT/US1993/009183 patent/WO1994007891A1/en active Application Filing
- 1993-10-01 AU AU52928/93A patent/AU5292893A/en not_active Abandoned
- 1993-10-04 IL IL107177A patent/IL107177A0/xx unknown
- 1993-10-05 TW TW082108227A patent/TW268943B/zh active
- 1993-10-06 MX MX9306234A patent/MX9306234A/es unknown
- 1993-10-07 ZA ZA937453A patent/ZA937453B/xx unknown
-
1994
- 1994-02-04 US US08/191,416 patent/US5428035A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5296478A (en) | 1994-03-22 |
WO1994007891A1 (en) | 1994-04-14 |
TW268943B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1996-01-21 |
MX9306234A (es) | 1994-05-31 |
US5428035A (en) | 1995-06-27 |
IL107177A0 (en) | 1994-01-25 |
ZA937453B (en) | 1995-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5292893A (en) | 1-substituted oxindoles and azaoxindoles as novel cognition enhancers | |
AU662997B2 (en) | Condensed heterocyclic derivative and weedkiller | |
AU3217897A (en) | Analogs of cc-1065 and the duocarmycins | |
AU3707093A (en) | Dynamically biased amplifier | |
AU3692393A (en) | Indole derivatives | |
EP0634836A3 (en) | Distributed amplifier and bidirectional amplifier | |
AU3349893A (en) | Indole derivatives | |
AU7446194A (en) | 4-arylamino-benzopyran and related compounds | |
AU3981293A (en) | Single-facer | |
AU3615593A (en) | Improved mild soap-synbar | |
AU4408693A (en) | Composite article | |
AU4098393A (en) | Laminate and use of the same | |
AU3397793A (en) | Binder and its uses | |
AU5692094A (en) | Novel n-(pyridylcarbonyl)benzazepine derivative and intermediate therefor | |
AU5201293A (en) | Debrominative chlorination of pyrroles | |
AU685767B2 (en) | Substituted benzazepinones | |
AU2327192A (en) | Indoles | |
AU6995594A (en) | Aryltriflates and related compounds | |
AU3783493A (en) | Indole antiinsectan metabolites | |
AU5049296A (en) | Novel epicholesterol dehydrogenase | |
AU2448292A (en) | Pyrimidine derivative and weedkiller | |
AU3359493A (en) | Determination of haptens | |
AU5054593A (en) | Thermal sorting | |
AU1764292A (en) | Re-catalyst and carrier | |
RU2003675C1 (ru) | "Водка особа "Водочка царска " |